Netherlands
Arsenal Capital’s IGM completes refinancing
Transaction features €25m unitranche from HIG WhiteHorse
Benelux Q3 dealflow remains subdued but value rockets
Dealflow remained subdued in Q3 but value soared thanks to handful of larger deals
Gimv injects €12.5m into Zorgbedrijven
GP to secure minority stake in clinic operator
PE-backed $3.3bn Lumileds carve-out delayed by US regulators
CFIUS expresses "unforeseen concerns" around the takeover
H2 offloads Isero to Grafton
H2 first invested in Isero in 2010
Parcom et al. acquire Imtech Marine
Latest subsidiary to be sold by troubled parent Imtech
BC Partners buys Dümmen Orange
BC Partners has acquired Dutch flower business Dümmen Orange in a secondary buyout from H2 Equity Partners.
Curetis eyes IPO on Euronext
Company was founded in 2007
Main’s Roxit to merge with Green Valley
First move in build-up strategy since July buyout
Main buys majority stake in Ymor
GP recently closed €85m fourth fund
Deal in Focus: Forbion to reap 50x on $1.55bn Dezima sale
Sale of Dezima could result in a staggering 50x return for Forbion
Forbion’s Dezima sold to Amgen
VC exits two years after backing the company's creation
Initial Capital in $1.9m round for BUX
Business to target growth in additional European markets
Forbion closes co-investment fund on €75m
Fund has already made three investments
HenQ closes third fund on €50m
Vehicle to target both seed and <€10m follow-up rounds
Liberty and Volta in €2m series-A for LookLive
Business targeting new partnerships with broadcast and retail brands
Main Capital holds €85m final close for fourth fund
Fund surpasses €75m target to hit hard-cap
Vendis backs Humanoid BIMBO
Final deal for GP's €111.5m first fund
Taylor Wessing merges with Deterink
Move to grant the firm an entry point into Dutch market
Avista’s Trimb acquires YouMedical
Acquisition forms part of nothern European buy-and-build platform
NVP appoints former deputy prime minister as chair
Move takes place as industry comes under mounting public scrutiny
Van den Ende launches €107m fund; rebrands as Endeit
Firm to be renamed to Endeit Capital
Sofinnova et al. in €72.8m series-C round for Merus
Third largest round observed by unquote" in Benelux so far in 2015
PHSC's Skin Vision raises €3m
Fund was led by Danish pharma company Leo Pharma